Literature DB >> 16894557

Tobacco smoke and bladder cancer--in the European Prospective Investigation into Cancer and Nutrition.

Bine Kjøller Bjerregaard1, Ole Raaschou-Nielsen, Mette Sørensen, Kirsten Frederiksen, Jane Christensen, Anne Tjønneland, Kim Overvad, Francoise Clavel Chapelon, Gabriele Nagel, Jenny Chang-Claude, Manuela M Bergmann, Heiner Boeing, Dimitrios Trichopoulos, Antonia Trichopoulou, Eleni Oikonomou, Franco Berrino, Domenico Palli, Rosario Tumino, Paolo Vineis, Salvatore Panico, Petra Hm Peeters, H Bas Bueno-de-Mesquita, Lambertus Kiemeney, Inger Torhild Gram, Tonje Braaten, Eiliv Lund, Carlos A Gonzalez, Göran Berglund, Naomi Allen, Andrew Roddam, Sheila Bingham, Elio Riboli.   

Abstract

The purpose of the present study was to investigate the association between smoking and the development of bladder cancer. The study population consisted of 429,906 persons participating in the European Prospective Investigation into Cancer and Nutrition (EPIC), 633 of whom developed bladder cancer during the follow-up period. An increased risk of bladder cancer was found for both current- (incidence rate ratio 3.96, 95% confidence interval: 3.07-5.09) and ex- (2.25, 1.74-2.91) smokers, compared to never-smokers. A positive association with intensity (per 5 cigarettes) was found among current-smokers (1.18, 1.09-1.28). Associations (per 5 years) were observed for duration (1.14, 1.08-1.21), later age at start (0.75, 0.66-0.85) and longer time since quitting (0.92, 0.86-0.98). Exposure to environmental tobacco smoke (ETS) during childhood increased the risk of bladder cancer (1.38, 1.00-1.90), whereas for ETS exposure as adult no effect was detected. The present study confirms the strong association between smoking and bladder cancer. The indication of a higher risk of bladder cancer for those who start smoking at a young age and for those exposed to ETS during childhood adds to the body of evidence suggesting that children are more sensitive to carcinogens than adults.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16894557     DOI: 10.1002/ijc.22169

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  20 in total

1.  A case-control study of smoking and bladder cancer risk: emergent patterns over time.

Authors:  Dalsu Baris; Margaret R Karagas; Castine Verrill; Alison Johnson; Angeline S Andrew; Carmen J Marsit; Molly Schwenn; Joanne S Colt; Sai Cherala; Claudine Samanic; Richard Waddell; Kenneth P Cantor; Alan Schned; Nathaniel Rothman; Jay Lubin; Joseph F Fraumeni; Robert N Hoover; Karl T Kelsey; Debra T Silverman
Journal:  J Natl Cancer Inst       Date:  2009-11-16       Impact factor: 13.506

2.  Environmental tobacco smoke in relation to bladder cancer risk--the Shanghai bladder cancer study [corrected].

Authors:  Li Tao; Yong-Bing Xiang; Renwei Wang; Heather H Nelson; Yu-Tang Gao; Kenneth K Chan; Mimi C Yu; Jian-Min Yuan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-10-15       Impact factor: 4.254

3.  Best practice in the treatment of nonmuscle invasive bladder cancer.

Authors:  Anastasios Anastasiadis; Theo M de Reijke
Journal:  Ther Adv Urol       Date:  2012-02

4.  Intervention of nicotine on MNU-induced bladder cancer in rats.

Authors:  Di Liu; Feng Pan; Bing Li; Xiaomin Han; Wencheng Li; Ying Shi; Zili Pang; Qijun Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-02-19

5.  Clearing the Air: Summarizing the Smoking-related Relative Risks of Bladder and Kidney Cancer.

Authors:  Mark P Purdue; Debra T Silverman
Journal:  Eur Urol       Date:  2016-04-27       Impact factor: 20.096

6.  Urothelial cancer and the diagnosis of subsequent malignancies.

Authors:  Deepak K Pruthi; Zoann Nugent; Piotr Czaykowski; Alain A Demers
Journal:  Can Urol Assoc J       Date:  2013 Jan-Feb       Impact factor: 1.862

7.  Persistence of urothelial carcinoma of the bladder risk among former smokers: results from a contemporary, prospective cohort study.

Authors:  Christopher J Welty; Jonathan L Wright; James M Hotaling; Parveen Bhatti; Michael P Porter; Emily White
Journal:  Urol Oncol       Date:  2013-03-15       Impact factor: 3.498

8.  Human NAD(P)H:quinone oxidoreductase 1 (NQO1) and sulfotransferase 1A1 (SULT1A1) polymorphisms and urothelial cancer risk in Taiwan.

Authors:  Yuan-Hung Wang; Ying-Huei Lee; Po-Tsang Tseng; Cheng-Huang Shen; Hung-Yi Chiou
Journal:  J Cancer Res Clin Oncol       Date:  2007-07-10       Impact factor: 4.553

9.  Agricultural workers and urinary bladder cancer risk in Egypt.

Authors:  Sania Amr; Rebecca Dawson; Doa'a A Saleh; Laurence S Magder; Nabiel N Mikhail; Diane Marie St George; Katherine Squibb; Hussein Khaled; Christopher A Loffredo
Journal:  Arch Environ Occup Health       Date:  2014       Impact factor: 1.663

10.  The association between personal habits and bladder cancer in Turkey.

Authors:  Fuat Demirel; Murat Cakan; Fatih Yalçinkaya; Murat Topcuoglu; Ugur Altug
Journal:  Int Urol Nephrol       Date:  2008-02-05       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.